Earnings History Data for Context Therapeutics Inc. (CNTX) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Context Therapeutics Inc.

Context Therapeutics Inc. is a women's oncology company developing advanced small molecule and immunotherapy treatments to transform care for hormone-driven breast and gynecological cancers. Context Therapeutics Inc. is headquartered in Philadelphia, PA.
Release Date Time Est. Time Symbol Name Market Cap (M) Rep. EPS Est. EPS Last years EPS SeekingAlpha Headline Price Change Ext. Hours Price Ext. Hours Change 52 Week Range Volume Avg. Volume Ext. Hours Volume Top Mover
21-03-2024 PM CNTX Context Therapeutics Inc. 18.00 -0.42 -0.35 0.00 Context Therapeutics reports FY results
[3/21/2024 10:44 AM]
1.09 -0.06 
(-5.22%)
1.24 0.09 
(7.83%)
0.47 - 1.69 80,882 50,000 23,202
09-11-2022 AH CNTX Context Therapeutics Inc. 19.00 -0.24 -0.25 0.00 Context Therapeutics GAAP EPS of -$0.24 beats by $0.01
[11/9/2022 5:36 PM]
1.14 -0.01 
(-0.87%)
1.12 -0.03 
(-2.61%)
0.95 - 10.87 92,002 120,000 1,755
11-05-2022 AH 4:00 PM ET
(May 11)
CNTX Context Therapeutics Inc. 22.00 -0.22 -0.24 0.00 Context Therapeutics GAAP EPS of -$0.22
[5/11/2022 4:41 PM]
1.35 0.06 
(4.65%)
1.21 -0.08 
(-6.20%)
1.27 - 10.87 95,774 190,000 4,836